You're always banging on about how the Stable Disease count to Progressive Disease count did not reach the goal set at the beginning of the canine b-cell lymphoma 2B trial.
But that was irrelevant by the end of the trial, because the trial revealed that the extension in the canine life was little affected by whether that measure, which was the whole point of this "bench mark". What's wrong with your memory that you cannot remember this crucial detail?
You're always banging on about how the Stable Disease count to...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.005(2.17%) |
Mkt cap ! $90.85M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 23.5¢ | 23.0¢ | $694 | 3.017K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 58444 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 19353 | 2 |
View Market Depth
| Last trade - 10.06am 02/05/2024 (20 minute delay) ? |
|
|||||
|
Last
23.5¢ |
Change
0.005 ( 2.17 %) |
||||
| Open | High | Low | Volume | ||
| 23.5¢ | 23.5¢ | 23.5¢ | 1000 | ||
| Last updated 10.35am 02/05/2024 ? | |||||
| PAA (ASX) Chart |